All Pharma News
price-trendAsk Us
After rejection, FDA accepts Xspray`s leukemia med resubmission

After rejection, FDA accepts Xspray`s leukemia med resubmission
FIERCE PHARMA
12 Feb 2024
Share Share
Xspray Pharma’s XS003 Achieves Superior Bioavailability Milestone

Xspray Pharma’s XS003 Achieves Superior Bioavailability Milestone
BUSINESSWIRE
21 Nov 2023
Share Share
FDA rejects Xspray`s would-be rival to BMS leukemia med Sprycel

FDA rejects Xspray`s would-be rival to BMS leukemia med Sprycel
Fraiser Kansteiner FIERCE PHARMA
12 Jul 2023
Share Share
Xspray Partners with EVERSANA for the Commercialization of Dasynoc

Xspray Partners with EVERSANA for the Commercialization of Dasynoc
PR NEWSWIRE
23 Feb 2023
Share Share
Bristol-Myers Sues XSpray to Block Copies of Blockbuster Sprycel

Bristol-Myers Sues XSpray to Block Copies of Blockbuster Sprycel
BLOOMBERG LAW
25 Feb 2022
Share Share